New patent for Nalpropion drug CONTRAVE

May 26, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are nineteen patents protecting…

The post New patent for Nalpropion drug CONTRAVE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.